Novo Nordisk A/S
CSE:NOVO B
Novo Nordisk A/S
CSE:NOVO B
Price:
259.9
DKK
1.05%
Market Closed
Market Cap:
kr1.2T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Novo Nordisk A/S
CSE:NOVO B
|
DK |
|
Daicel Corp
TSE:4202
|
JP |
|
Vallourec SA
OTC:VLOUF
|
FR |
|
S
|
SNTEnergy Co Ltd
KRX:100840
|
KR |
Multiples-Based Value
The Multiples-Based Value of one
NOVO B
stock under the Base Case scenario is
hidden
DKK.
Compared to the current market price of 259.9 DKK,
Novo Nordisk A/S
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NOVO B Multiples-Based Value
LOCKED
Multiples Across Competitors
NOVO B Competitors Multiples
Novo Nordisk A/S Competitors
Novo Nordisk A/S Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.7 | 11.3 | 8.3 | 9.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
875.9B USD | 13.4 | 42.4 | 28.7 | 30.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
563.9B USD | 5.9 | 26.8 | 17.2 | 22 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
234.5B GBP | 5.3 | 30.4 | 16.8 | 23.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 12.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.3B CHF | 5 | 20.3 | 12.6 | 16.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.7B USD | 4.5 | 16.1 | 10 | 12.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.7B USD | 2.5 | 20.2 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.1B USD | 2.5 | 17.2 | 7.2 | 8.9 | |
| UK |
|
GSK plc
XETRA:GS71
|
100.3B EUR | 2.7 | 15.3 | 8.3 | 10.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
